AbCellera Biologics Inc

NASDAQ:ABCL  
8.61
-0.47 (-5.18%)
Debt Financing / Related

Abcellera Announces Secondary Private Sale Of 11.9 Mln Common Shares

Published: 06/10/2021 21:30 GMT
AbCellera Biologics Inc (ABCL) - Abcellera Announces Secondary Private Sale of 11.9 Million Common Shares.
Abcellera Biologics Inc - Certain Entities Associated With CEO Carl Hansen Sold Shares to Institutional Investors.